Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

Research & Selected Publications

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy
Authors:

Wang Y, Larson MC, Hwang SR, one or more additional authors omitted Nizamuddin IA, one or more additional authors omitted Martin P

Journal & Year:

Blood Cancer J | 2026

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study
Authors:

Hamby M, Egleston BL, Frosch ZAK, one or more additional authors omitted Nizamuddin IA, one or more additional authors omitted Barta SK

Journal & Year:

Blood Cancer J | 2026

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma
Authors:

Alderuccio JP, Baggio D, Han S, one or more additional authors omitted Nizamuddin IA, one or more additional authors omitted Cwynarski K

Journal & Year:

Blood | 2026

Large B cell lymphoma microenvironment archetype profiles
Authors:

Li X, Singhal K, Deng Q, one or more additional authors omitted Nizamuddin I, one or more additional authors omitted Green MR

Journal & Year:

Cancer Cell | 2025

Bispecific antibodies in follicular lymphoma
Authors:

Nizamuddin IA, Bartlett NL

Journal & Year:

Haematologica | 2025

Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibody Use in Earlier Lines of Treatment of Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma
Authors:

Nizamuddin IA, Ghobadi A

Journal & Year:

Am Soc Clin Oncol Educ Book | 2025

BV and beyond: how to incorporate novel agents into PTCL management
Authors:

Nizamuddin IA, Mehta-Shah N

Journal & Year:

Hematology Am Soc Hematol Educ Program | 2024